AzTrials
AzTrials

Hemiplegic Cerebral PalsyNEUROLOGYNCT06704880

CONSTRAINT-INDUCED MOVEMENT THERAPY VERSUS CROSS EDUCATION IN CHILDREN WITH CEREBRAL PALSY

A study testing rehabilitation in people with Hemiplegic Cerebral Palsy, run by Imam Abdulrahman Bin Faisal University at 1 site in Saudi Arabia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This clinical trial aims to Compare the effectiveness of lower limb CIMT and the Strength Training of the Non-Hemiplegic lower limb on motor performance in hemiplegic children with CP. Read more about this study

Who is it for?
Ages 5 to 15 years
Conditions the study is for
Hemiplegic Cerebral Palsy
What is being tested?
rehabilitation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSaudi Arabia
Study dates
30 Nov 2024to 29 Apr 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children with hemiplegic cerebral palsy aged age between 4 and 10.
  • (GMFCS) levels I, II and III.
  • Able to follow therapist instructions during training session.

Who cannot join

  • Lack of patient's cooperation.
  • Difficulty wearing constraint method due to severe joint deformation or/and contracture.
  • Patients were treated with botulinum toxin during the last 3 months.
  • Seizure disorder not fully controlled by medication.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

abdullah owaid Alanazi, PhD student contact

800-555-5555

aalanazi112@moh.gov.sa

alaa ibrahim ismail, professor contact

aiibrahim@iau.edu.sa

Saudi Arabia1 site
  • Imam Abdulrahmn Alfaisal University

    Dammam

    abdullah owaid alanazi, PhD student, 00966503035285, aalanazi112@moh.gov.sa

Other trials in Saudi Arabia

About this study

Official title: Lower Limb Constraint-induced Movement Training Versus Strength Training of the Non-hemiplegic Lower Limb on Motor Performance in Children With Hemiplegic Cerebral Palsy: A Randomized Control Trial.

This clinical trial aims to Compare the effectiveness of lower limb CIMT and the Strength Training of the Non-Hemiplegic lower limb on motor performance in hemiplegic children with CP.

Participants will:

diagnosed with hemiplegic cerebral palsy treated with CIMT or Strength training (cross-education) for a non-hemiplegic limb for 8 weeks.

3 sessions per week. Measurements will be taken at baseline and then at the end of the 8 weeks.

Read the detailed description

Method:

32 children with hemiplegic CP will be equally and randomly allocated to two groups (group A and B). group A will receive lower limb CIMT for the non- hemiplegic limb using whole leg orthosis and Group B will receive strengthen training for the non-hemiplegic lower limb. Both groups will receive routine physical therapy for the hemiplegic lower limb. Both groups will receive 60 minutes training session for 3 sessions per week for 8 consecutive weeks. Assessment will be at baseline then at the end of trial.

Being tested
rehabilitation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • rehabilitationOther

    children in the CIMT group will RECIEVE lower limb CIMT for the non-hemiplegic limb using whole leg orthosis. Children in cross-education group will receive strengthening training for the non-hemiplegic lower limb

Study groups in NCT06704880
Study groupRoleWhat they receive
CIMT GROUPExperimentalNot described
Receives: Other: rehabilitation
STRENGHTH TRAINING GROUP (cross education)ExperimentalNot described
Receives: Other: rehabilitation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. gait speed

    gait spatiotemporal parameter

    Measured: at base line then at the end of the 8 weeks

  2. cadence gait spatiotemporal parameter

    gait spatiotemporal parameter

    Measured: at base line then at the end of the 8 weeks

  3. step length

    gait spatiotemporal parameter

    Measured: at base line then at the end of the 8 weeks

  4. stride length

    gait spatiotemporal parameter

    Measured: at base line then at the end of the 8 weeks

Secondary outcomes (4)
  1. Pediatric balance scale

    Pediatric balance scale The Pediatric Balance Scale is a modified version of the Berg Balance Scale that is used to assess functional balance skills in school-aged children. The scale consists of 14 items that are scored from 0 points (lowest function) to 4 points (highest function) with a maximum score of 56 points.

    Measured: at base line then at the end of the 8 weeks

  2. 6 Minute walk test (6MWT)

    endurance measurement

    Measured: at base line then at the end of the 8 weeks

  3. Modified Ashworth scale

    measuring muscle tone Scoring 0 No Increased in tone

    1. Slight increase in tone giving a catch when the limb is moved in flexion or extension 1+ Slight increase in muscle tone, indicated by a catch followed by minimal resistance throughout range of motion (ROM)
    2. More marked increase in tone through most of the ROM, but the limb easily flexed
    3. Considerable increase in tone, passive movement difficult
    4. Limb rigid in flexion or extension

    Measured: at base line then at the end of the 8 weeks

  4. Handheld dynamometer

    measuring muscles strength

    Measured: at base line then at the end of the 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2024
  2. Study start30 Nov 2024 (estimated)
  3. Primary completion28 Feb 2025 (estimated)
  4. Study completion29 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06704880
Sponsor's protocol ID
IRB-PGS-2024-03-156
Acronym
NEUROLOGY
Status last verified
Nov 2024
First submitted
9 Sep 2024
Last updated
26 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing rehabilitation in people with Hemiplegic Cerebral Palsy, run by Imam Abdulrahman Bin Faisal University at 1 site in Saudi Arabia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact abdullah owaid Alanazi, PhD student (800-555-5555, aalanazi112@moh.gov.sa), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

gait speed (time frame: at base line then at the end of the 8 weeks). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in